Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: biomarkers in platelets for diagnosing Parkinson

PROVIDER: PRJNA732803 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14663521_1.fastq.gz	Fastqsanger.gz
	SRR14663521_2.fastq.gz	Fastqsanger.gz
	SRR14663522_1.fastq.gz	Fastqsanger.gz
	SRR14663522_2.fastq.gz	Fastqsanger.gz
	SRR14663523.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 39

Similar Datasets

RNA sequencing of maternal plasma

Project description:RNA sequency was performed on maternal plasma from pregnant women carrying nsCLP foetuses or healthy foetuses. The aim of this study is to explore potential promising biomarkers for diagnosing nsCLP.

2024-03-22 | GSE169294 | GEO

Small RNA Sequencing of Different Blood Compartments

Project description:We studied microRNA levels in different blood compartments (erythrocytes, buffy coat, platelets (gel-filtrated or washed), PRP, PPP, and the supernatant of Convulxin-stimulated platelets). The aim of this study was to identify/confirm platelet-enriched miRNAs as biomarkers of platelet activation.

2022-04-12 | GSE200251 | GEO

Circulating miRNome expression profiling in Behçet's disease

Project description:Circulating plasma miRNAs profiling in platelets-free plasma samples from Behçet's disease patients compared with healthy subjects, aimed to both pathogenesis elucidation and candidate non-invasive biomarkers identification.

2020-04-01 | GSE145191 | GEO

Project description:the normal samples of identification biomarkers in Parkinson

| PRJNA732990 | ENA

Changes in circulating miRNA expression in right heart remodeling due to pulmonary hypertension

Project description:Clinical practice currently faces a significant shortfall in specific biomarkers needed for diagnosing right ventricular (RV) remodeling in patients with pulmonary hypertension (PH). MiRNAs are crucial regulators of cardiovascular development, influencing processes like angiogenesis, cardiomyocyte differentiation, cell cycle, cardiac electrical activity, and cardiomyocyte growth. Furthermore, circulating miRNAs are cell-or tissue-specific, relatively stable in serum, and resistant to degradation factors. These properties make serum miRNAs possible promising biomarkers for predictive diagnosis of cardiovascular disease (CVD). This study systematically screened and identified candidate serum miRNAs as potential diagnostic biomarkers for RV remodeling in PH patients.

2025-01-18 | GSE287146 | GEO

Non-Invasive Biomarkers for Diagnosing and Anticipating Post-Transplant Complications

Project description:Non-Invasive Biomarkers for Diagnosing and Anticipating Post-Transplant Complications

| PRJNA559410 | ENA

Non-Invasive Biomarkers for Diagnosing and Anticipating Post-Transplant Complications

Project description:Non-Invasive Biomarkers for Diagnosing and Anticipating Post-Transplant Complications

| PRJNA559412 | ENA

microRNAs expression profile in human apheresis platelets during storage

Project description:To investigate the microRNAs (miRNAs) expression profiles in human apheresis platelet under platelet storage lesion (PSL), and predict the potential biomarkers in the process of PSL. miRNAs profiles of platelets were tested by illumina HiSeq2500 between PSL and nonPSL. 13 miRNAs were chosen to validate by real-time PCR, the result was consistent with the sequencing results.

2025-04-23 | GSE243571 | GEO

Serum LncRNAs as Early Potential Biomarkers for the Prediction of Pregnancy-induced hypertension,including Preeclampisa

Project description:To identify potential lncRNAs as early circulating biomarkers for pregnancy-induced hypertension (PIH), including both gestational hypertension (GH) and preeclampsia (PE), we sought to determine the lncRNA expression profiles in the serum of patients with PE before the 20th week of gestation and evaluated the efficacy of lncRNAs for diagnosing PIH before the onset of clinical symptoms. The screening phase assessed lncRNA expression profiles with a human lncRNA microarray in 5 pairs of serum samples (5 PE patients and 5 matched controls).

2021-06-08 | GSE150317 | GEO

Differences in platelet miRNA profiles between patients with coronary artery disease and healthy controls.

Project description:Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. The aim of this study was to investigate whether differences in miRNA expression levels in platelets can be found (i) between patients with premature CAD and healthy controls and (ii) within healthy controls after and before aspirin and statin administration.

2015-06-22 | GSE59421 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data